Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Warrick Albuterol Medicaid "Overpayments" Total $14.6 Mil. -Texas Argues

Executive Summary

Warrick Pharmaceuticals is responsible for $14.6 mil. in albuterol reimbursement overpayments made by the Texas Medicaid Program, Texas Attorney General John Cornyn argued in a lawsuit filed Sept. 7 in Travis County, Texas state court.
Advertisement

Related Content

Dey will pay
Schering GMPs Linger: Whistleblower Suit Filed, Consent Decree Extended
AARP Health Litigation Brief Supports Michigan Supplemental Rebates
Merck, Lilly, J&J Pricing Practices Praised By AWP "Whistleblower"
Rx Pricing/Marketing Defense Based On "Industry Standard" Losing Viability
SmithKline, Bayer Subpoenaed In Medicaid Repackaging Investigation
Bayer Drug Prices To Be Monitored By HHS Under Medicaid Fraud Settlement
TAP, SB Pressed By Rep. Bliley To Provide More Drug Pricing Documents
TAP, SB Pressed By Rep. Bliley To Provide More Drug Pricing Documents
Congressional Drug Pricing Investigation Receives Boost From Rep. Bliley
Advertisement
UsernamePublicRestriction

Register

PS036616

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel